Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MGLL | Q99685 | 15/20 | 0.42 |
| ▸ | GSK3A | P49840 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | FAAH | O00519 | 7/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | GMNN | O75496 | 1/20 | 0.36 |
| ▸ | THPO | P40225 | 1/20 | 0.36 |
| ▸ | BLM | P54132 | 1/20 | 0.36 |
| ▸ | PMP22 | Q01453 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.35 |
| ▸ | TLR9 | Q9NR96 | 2/20 | 0.35 |
| ▸ | PKM | P14618 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | XBP1 | P17861 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL709406 | 0.79 | MGLL (0.42) | MGLLGSK3AGSK3BFAAHNPSR1 | |
| SCHEMBL4340966 | 0.73 | — | — | |
| SCHEMBL24003668 | 0.73 | — | — | |
| SCHEMBL16256331 | 0.73 | — | — | |
| SCHEMBL5577325 | 0.71 | MGLL (0.43) | MGLLGSK3AGSK3BFAAHNPSR1 | |
| SCHEMBL19954787 | 0.69 | MGLL (0.35) | MGLLGSK3AGSK3BFAAHNPSR1 | |
| SCHEMBL22407268 | 0.68 | MGLL (0.46) | MGLLFAAHNPSR1ALDH1A1LMNA | |
| SCHEMBL19057261 | 0.67 | MGLL (0.46) | MGLLGSK3AGSK3BFAAHNPSR1 | |
| SCHEMBL19848642 | 0.67 | MGLL (0.39) | MGLLGSK3AGSK3BFAAHNPSR1 | |
| SCHEMBL11749637 | 0.67 | ALDH1A1 (0.47) | MGLLGSK3AGSK3BFAAHALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 183 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118755466-B | Pressure production integrated emulsion type fracturing fluid | 陕西万德石油科技有限公司 | 2024-12-20 | — | — | CN | claimed |
| CN-118755466-A | Pressure production integrated emulsion type fracturing fluid | 陕西万德石油科技有限公司 | 2024-10-11 | — | — | CN | claimed |
| CN-118599107-A | High-strength, high-toughness, high-heat-resistance and detachable thermosetting polymer based on dithiobismaleimide-diallyl bisphenol A copolymerization and preparation method thereof, fiber composite material and preparation method thereof | 中国工程物理研究院化工材料研究所 | 2024-09-06 | — | — | CN | claimed |
| CN-118440237-A | Self-repairing polymer, preparation method and application thereof, self-repairing coating, cable and communication equipment | 武汉烽火锐拓科技有限公司 | 2024-08-06 | — | — | CN | claimed |
| CN-118126321-A | Ultra-high heat-resistant and detachable recovery type thermosetting polymer based on self-polymerization of dithiobismaleimide and preparation method thereof | 中国工程物理研究院化工材料研究所 | 2024-06-04 | — | — | CN | claimed |
| CN-117203225-A | Artificial TRAP cage, use thereof and preparation method thereof | 雅盖隆大学 | 2023-12-08 | — | — | CN | claimed |
| CN-116183923-A | Panel for detecting APC/tumor immune co-stimulatory molecules | 杭州奥明瑞康医学检验实验室有限公司 | 2023-05-30 | — | — | CN | claimed |
| CN-115997016-A | Composition comprising nucleic acid nanoparticles having modular functional groups | 西克斯福德生物科学有限公司 | 2023-04-21 | — | — | CN | claimed |
| CN-108026527-B | Defined multiconjugated oligonucleotides | MPEG LA有限责任公司 | 2022-05-10 | — | — | CN | claimed |
| US-11059938-B2 | Film composition and a film prepared thereby | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2021-07-13 | — | — | US | claimed |
| EP-1446418-A4 | INTEGRIN TARGETING COMPOUNDS | SCRIPPS RESEARCH INST (US) | 2006-05-17 | — | — | EP | claimed |
| JP-2005514430-A | — | — | 2005-05-19 | — | — | JP | claimed |
| EP-1446418-A2 | INTEGRIN TARGETING COMPOUNDS | The Scripps Research Institute (US) | 2004-08-18 | — | — | EP | claimed |
| EP-1443963-A2 | ANTIBODY TARGETING COMPOUNDS | The Scripps Research Institute (US) | 2004-08-11 | — | — | EP | claimed |
| US-20030190676-A1 | Antibody targeting compounds | THE SCRIPPS RESEARCH INSTITUTE (US) | 2003-10-09 | — | — | US | claimed |
| US-20030175921-A1 | Antibody targeting compounds | THE SCRIPPS RESEARCH INSTITUTE | 2003-09-18 | — | — | US | claimed |
| WO-2003059251-A2 | ANTIBODY TARGETING COMPOUNDS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2003-07-24 | — | — | WO | claimed |
| US-20030129188-A1 | Integrin targeting compounds | THE SCRIPPS RESEARCH INSTITUTE | 2003-07-10 | — | — | US | claimed |
| WO-2003034995-A2 | INTEGRIN TARGETING COMPOUNDS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2003-05-01 | — | — | WO | claimed |
| US-4004627-A | Pneumatic tire with sidewall composition | THE GOODYEAR TIRE & RUBBER COMPANY (US) | 1977-01-25 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030175921-A1 | Antibody targeting compounds | CD47, CD22, FCGR2A | MGLL 4286/4885GSK3A 1635/4885GSK3B 1702/4885 |
| US-20030129188-A1 | Integrin targeting compounds | ITGAV, ITGB1, ITGB2 | MGLL 4522/4885GSK3A 2214/4885GSK3B 2060/4885 |
| US-20030190676-A1 | Antibody targeting compounds | CD47, CD22, FCGR2A | MGLL 4286/4885GSK3A 1635/4885GSK3B 1702/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.